CAS 98319-24-5
:3-osso-4-aza-5A-androstano-17B-(N-terz-butilcarbossamide)
- 17β-(N-tert-Butylcarbamoyl)-4-aza-5α-androstan-3-one
- 3-Oxo-4-Aza-5A-Androstane-17B-(N-T-Butyl)Carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- Androstane-N-terbutyl-3-oxo-4-aza-5 alfa-17 beta-carboxamide
- 17-Beta-(N-Butylcarbamoyl)-4-Aza-5-Alpha-Androstan-3-One
- 17β-(t-Butylcarbamoyl)-4-aza-5a-androstan-3-one
- Dihydroproscar
- N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide
- Dihydro Finasteride
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Finasteride Related Compound A
CAS:Cyclic amides and their derivatives, nesoiFormula:C23H38N2O2Colore e forma:White Off-White PowderPeso molecolare:347.57Dihydrofinasteride
CAS:DihydrofinasterideFormula:C23H38N2O2Purezza:0.98Colore e forma:SolidPeso molecolare:374.56Ref: 4Z-F-0524
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta3-Oxo-4-aza-5A-androstane-17-β-(N-tert-butylcarboxamide); 98%
CAS:Formula:C23H38N2O2Purezza:(HPLC) ≥ 98.0%Colore e forma:White to off-white powderPeso molecolare:374.56Dihydroproscar
CAS:Formula:C23H38N2O2Purezza:≥ 95.0% (anhydrous basis)Colore e forma:White to off-white powderPeso molecolare:374.56Finasteride EP Impurity A
CAS:Formula:C23H38N2O2Colore e forma:White To Off-White SolidPeso molecolare:374.57(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-Dimethylethyl)hexadecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
CAS:Formula:C23H38N2O2Purezza:98%Colore e forma:SolidPeso molecolare:374.5600N-(1,1-Dimethylethyl)-3-oxo-4-aza-5alpha-androstane-17beta-carboxamide (Dihydrofinasteride)
CAS:Prodotto controllatoFormula:C23H38N2O2Colore e forma:NeatPeso molecolare:374.56Dihydro Finasteride
CAS:Impurity Finasteride EP Impurity A
Applications Dihydro Finasteride (Finasteride EP Impurity A) is the reduced product of Finasteride (F342000): a mechanism-based inhibitor of human prostate and skin steroid 5α-reductase. It forms an enzyme-bound NADP-dihydrofinasteride adduct during this inhibitory process.
References Bull, H.G. et al.: Am. J. Chem. Soc., 118, 2359 (1996); Liang, T. et al.: Endocrinol., 117, 571 (1985); Ellsworth, K.P. et al.: J. Steroid Bioche. Mol. Biol., 66, 271 (1998);Formula:C23H38N2O2Colore e forma:NeatPeso molecolare:374.56Ref: ST-EA-CP-F14001
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaDihydroproscar
CAS:Dihydroproscar is a synthetic retinoid that is clinically used to treat benign prostatic hyperplasia (BPH). It has been shown to inhibit the synthesis of 3β-hydroxysteroid, which is necessary for the conversion of testosterone to dihydrotestosterone. Dihydroproscar also has a denaturing effect on proteins and inhibits the in vitro synthesis of DNA and RNA. The second-order rate constant for the reaction of dihydroproscar with ribonucleotides is about 1.4 times faster than that for other retinoids. Dihydroproscar has pharmacokinetic properties that are similar to those of other retinoids, including fatty acids and hydrogen chloride.
Formula:C23H38N2O2Purezza:Min. 97 Area-%Colore e forma:PowderPeso molecolare:374.56 g/mol3-Oxo-4-aza-5-α-androstane-17-β-N-t-butylcarboxamide
CAS:Formula:C23H38N2O2Purezza:98%Colore e forma:SolidPeso molecolare:374.569












